Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TOKAI PHARMACEUTICALS INC

Delayed Nasdaq  -  03:58 2017-05-12 pm EDT
6.130 USD   -3.92%
11/14ELEDON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
11/14Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
11/14Transcript : Eledon Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 2022
CI
SummaryChartsNewsRatingsCalendarCompanyFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about TOKAI PHARMACEUTICALS INC
11/14Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/14Transcript : Eledon Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 202..
CI
11/14Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
GL
11/03Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, Novemb..
GL
11/03Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, Novemb..
GL
10/25Eledon Pharmaceuticals Announces Upcoming Presentations at ASN's Kidney Week 2022 and N..
AQ
10/24Eledon Pharmaceuticals Announces Upcoming Presentations at ASN's Kidney Week 2022 and N..
GL
10/03Eledon Pharmaceuticals to Participate in Two Upcoming Conferences
GL
10/03Eledon Pharmaceuticals to Participate in Two Upcoming Conferences
AQ
09/22Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
GL
09/06Eledon Pharmaceuticals Gets FDA Clearance for Investigational New Drug Application for ..
MT
09/06Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubar..
GL
09/06Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubar..
AQ
09/06Eledon Pharmaceuticals, Inc. Receives FDA Clearance of IND Application to Evaluate Tego..
CI
08/29Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences
GL
More most relevant news
All news about TOKAI PHARMACEUTICALS INC
11/14ELEDON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Conditi..
AQ
11/14Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/14Transcript : Eledon Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 202..
CI
11/14Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
GL
11/03Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, Novemb..
GL
11/03Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, Novemb..
GL
10/25Eledon Pharmaceuticals Announces Upcoming Presentations at ASN's Kidney Week 2022 and N..
AQ
10/24Eledon Pharmaceuticals Announces Upcoming Presentations at ASN's Kidney Week 2022 and N..
GL
10/03Eledon Pharmaceuticals to Participate in Two Upcoming Conferences
GL
10/03Eledon Pharmaceuticals to Participate in Two Upcoming Conferences
AQ
More news
News in other languages on TOKAI PHARMACEUTICALS INC
11/14Eledon Pharmaceuticals, Inc. annonce ses résultats pour le troisième trimestre et les n..
09/06Eledon Pharmaceuticals obtient l'autorisation de la FDA pour la demande de nouveau médi..
09/06Eledon Pharmaceuticals, Inc. reçoit l'approbation de la FDA pour la demande de IND pour..
08/11Eledon Pharmaceuticals, Inc. annonce ses résultats pour le deuxième trimestre et le sem..
08/01Eledon Pharmaceuticals reçoit l'autorisation de la FDA pour une demande de DNR visant à..
07/18Eledon Pharmaceuticals administre la dose au premier patient de l'étude sur le Tegoprub..
07/18Eledon Pharmaceuticals annonce le dosage du premier patient dans l'essai de phase 1B év..
06/09Eledon déclare que la FDA accorde la désignation de médicament orphelin au Tegoprubart ..
05/31Eledon annonce des résultats positifs de l'essai de phase 2a du Tegoprubart démontrant ..
05/12Eledon Pharmaceuticals, Inc. annonce ses résultats pour le premier trimestre clos le 31..
More news
Analyst Recommendations on TOKAI PHARMACEUTICALS INC
06/01SVB Securities LLC Adjusts Price Target for Eledon Pharmaceuticals to $26 From $33, Rei..
MT
2021HC Wainwright Adjusts Eledon Pharmaceuticals' Price Target to $25 From $35, Keeps Buy R..
MT
2021Eledon Pharmaceuticals : SVB Leerink Adjusts Price Target on Eled..
MT
2021Eledon Pharmaceuticals : Cantor Fitzgerald Starts Eledon Pharmace..
MT
2021Eledon Pharmaceuticals : SVB Leerink Starts Eledon Pharmaceutical..
MT
More recommendations
Press releases
11/14ELEDON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Conditi..
AQ
11/14Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
GL
11/03Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, Novemb..
GL
11/03Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, Novemb..
GL
10/25Eledon Pharmaceuticals Announces Upcoming Presentations at ASN's Kidney Week 2022 and N..
AQ
More press releases
Upcoming event on TOKAI PHARMACEUTICALS INC